TauroPace™

TauroPace™ is certified for use during procedures of placing or revising CIEDs, including: 

• pacemakers (PM) 

• implantable cardioverter defibrillators (ICD)  

• PMs and ICDs able to deliver cardiac resynchronization therapy (CRT-P, CRT-D) 

• cardiac contractility modulation (CCM) 

• subcutaneous ICD (S-ICD) 

• leadless PMs  

• implantable or injectable loop recorders or monitors (ILR/ILM)  

• all respective hardware (generator, leads, torque wrench, dilators, sheaths, wires, etc.)  

• The main active ingredient of TauroPace™ is taurolidine.  

• Taurolidine has a broad antimicrobial activity against all relevant pathogens, including (but not limited to) multi-resistant superbugs (e.g. MRSA, MRSE, Klebsiella, Candida species). 

• no severe adverse device effects (SADE) reported 

• no contraindications known other than pre-existing allergies against taurolidine or polyvinylpyrrolidone (PVP) – either not reported to date 

• 100 ml vials (one vial to be used per patient/procedure) 
• storage at temperatures between 15 °C and 25 °C (do not freeze!)